Impact of induction intensity and transplantation on outcomes of patients with complex karyotype and TP53-mutated acute myeloid leukemia

被引：0
|
作者：
Omer Jamy
Kendall Diebold
Kenneth Davis
Kimo Bachiashvili
Sravanti Rangaraju
Pankit Vachhani
Kelly N. Godby
Donna Salzman
Ravi Bhatia
机构：
[1] University of Alabama at Birmingham,Division of Hematology and Oncology, Department of Medicine
[2] University of Alabama at Birmingham,School of Medicine
来源：
Bone Marrow Transplantation | 2023年 / 58卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：823 / 825
页数：2
相关论文
共 50 条
  • [21] Outcomes of Patients with TP53-Mutated Myeloid Neoplasms (TP53-MN) and the Role of Allogenic Blood or Marrow Transplantation (alloBMT)
    Pasca, Sergiu
    Haldar, Saurav D.
    Ambinder, Alexander J.
    Webster, Jonathan
    Jain, Tania
    Dalton, William Brian
    Prince, Gabrielle T.
    Ghiaur, Gabriel
    DeZern, Amy E.
    Gojo, Ivana
    Webster, Jonathan Allen
    Schulz, Cory
    Stokvis, Kristin
    Levis, Mark J.
    Jones, Richard J.
    Gondek, Lukasz P.
    BLOOD, 2022, 140 : 10629 - 10631
  • [22] Treatment patterns and outcomes of patients with TP53-mutated chronic lymphocytic leukemia
    Hwang, Steven
    Wang, Yucai
    Rabe, Kari
    Williams-Watley, Marquise
    Kenderian, Saad
    Muchtar, Eli
    Hampel, Paul
    Kay, Neil
    Koehler, Amber
    Behnken, Amy
    Leis, Jose
    Braggio, Esteban
    Shi, Min
    Viswanatha, David
    Van Dyke, Daniel
    Slager, Susan
    Parikh, Sameer
    He, Rong
    Ding, Wei
    LEUKEMIA & LYMPHOMA, 2023, 64 : S84 - S85
  • [23] Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting cell cycle checkpoint
    Gwak, Daehyeon
    Kim, Dongchan
    Jang, Heejun
    Liu, Jun
    Min, Suji
    Byun, Ja Min
    Koh, Youngil
    Hong, Junshik
    Yoon, Sung-Soo
    Shin, Dong-Yeop
    CANCER RESEARCH, 2024, 84 (06)
  • [24] TP53-Mutated Acute Myeloid Leukemia Patients Treated with Intensive Therapies Have Superior Outcomes: A Single Institution, Retrospective Study
    Sumransub, Nuttavut
    Steinwand, Gabriel K.
    Lee, Yoonkyu
    Cao, Qing
    Allred, Jeremy R.
    Ramesh, Vidhyalakshmi
    Myers, Chad L.
    Sachs, Zohar
    BLOOD, 2023, 142
  • [25] Activity of venetoclax-based therapy in TP53-mutated acute myeloid leukemia.
    Shoukier, Mahran
    Konopleva, Marina
    Dinardo, Courtney Denton
    Ravandi, Farhad
    Andreeff, Michael
    Garcia-Manero, Guillermo
    Jabbour, Elias
    Daver, Naval Guastad
    Borthakur, Gautam
    Pemmaraju, Naveen
    Montalban-Bravo, Guillermo
    Benton, Christopher Brent
    Short, Nicholas James
    Bhalla, Kapil N.
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    Kadia, Tapan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [26] Impact of TP53 Mutated Subclones in Acute Myeloid Leukemia
    Pabst, Gabriel
    Prochazka, Katharina
    Pregartner, Gudrun
    Rucker, Frank G.
    Heitzer, Ellen
    Woelfler, Albert
    Zebisch, Armin
    Berghold, Andrea
    Dohner, Konstanze
    Sill, Heinz
    BLOOD, 2018, 132
  • [27] Clinical Outcomes of Patients (pts) with TP53-Mutated Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS): A Single Center Experience
    Bewersdorf, Jan Philipp
    Shallis, Rory M.
    Gowda, Lohith
    Hager, Karl
    Podoltsev, Nikolai A.
    Gore, Steven D.
    Prebet, Thomas
    Halene, Stephanie
    Isufi, Iris
    Foss, Francine M.
    Huntington, Scott F.
    Kim, Tae Kon
    Pillai, Manoj M.
    Parker, Terri L.
    Neparidze, Natalia
    Bar, Noffar
    Seropian, Stuart
    Siddon, Alexa J.
    Zeidan, Amer M.
    BLOOD, 2019, 134
  • [28] Venetoclax and hypomethylating agents in TP53-mutated acute myeloid leukaemia
    Aldoss, Ibrahim
    Zhang, Jianying
    Pillai, Raju
    Shouse, Geoffrey
    Sanchez, James F.
    Mei, Matthew
    Nakamura, Ryotaro
    Stein, Anthony S.
    Forman, Stephen J.
    Marcucci, Guido
    Pullarkat, Vinod
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (02) : E45 - E48
  • [29] Immunohistochemistry for p53 Might Lead to Prompter Treatment in TP53-Mutated Acute Myeloid Leukemia
    Boiocchi, Leonardo
    Crabbe, Andrew
    Brunner, Andrew
    Fathi, Amir T.
    Hasserjian, Robert
    Nardi, Valentina
    MODERN PATHOLOGY, 2019, 32
  • [30] Immunohistochemistry for p53 Might Lead to Prompter Treatment in TP53-Mutated Acute Myeloid Leukemia
    Boiocchi, Leonardo
    Crabbe, Andrew
    Brunner, Andrew
    Fathi, Amir T.
    Hasserjian, Robert
    Nardi, Valentina
    LABORATORY INVESTIGATION, 2019, 99
12345